Norberg, Helena http://orcid.org/0000-0002-6785-2895
Andersson, Therese http://orcid.org/0000-0002-5119-8411
Håkansson, Erik http://orcid.org/0000-0003-1545-178X
Ängerud, Karin Hellström http://orcid.org/0000-0002-7918-6121
Lindmark, Krister http://orcid.org/0000-0002-5756-7791
Funding for this research was provided by:
Heart Foundation of Northern Sweden
Umea University
Article History
Received: 18 April 2024
Accepted: 29 May 2024
First Online: 10 June 2024
Declarations
:
: The use of pseudonymized patient data for the purpose of this study was approved by The Regional Ethical Review Board in Umeå (registration number 2015-419-31), the Swedish Ethical Review Authority, Sweden, (registration number 2023-03695-01), and the Umeå University Hospital. The study was carried out in accordance with the Declaration of Helsinki. Since the study was based on existing data retrospectively retrieved from medical records of routine care, ethical approval was granted without the requirement of patient consent. The research data is stored and handled in accordance with the Umeå University data management principles.
: Authors HN, EH, KHÄ, and KL have no relevant financial or non-financial interests to disclose. TA reports speaker honoraria from Astra Zeneca, Boerhinger Ingelheim, Pharmacosmos and Vifor Pharma.